Medpace Holdings, Inc. (NASDAQ:MEDP) reported Q2 2017 earnings this Afternoon, coming in at $0.38 per share, beating Wall Street’s estimates of $0.30 per Share. Revenue for the quarter came in at $94.60 million beating analyst estimates of $92.71 million
Analyst Coverage For Medpace Holdings, Inc. (NASDAQ:MEDP)
These are 3 Hold Ratings, 3 Buy Ratings .
The current consensus rating for Medpace Holdings, Inc. (NASDAQ:MEDP) is Buy (Score: 2.50) with a consensus target price of $32.63 , a potential (18.94% upside)Recent Insider Trading for Medpace Holdings, Inc. (NASDAQ:MEDP)
- On 8/18/2016 August J Troendle, CEO, bought 10,000 with an average share price of $27.98 per share and the total transaction amounting to $279,800.00.
- On 8/17/2016 Susan E Burwig, Insider, bought 19,211 with an average share price of $29.21 per share and the total transaction amounting to $561,153.31.
- On 8/16/2016 August J Troendle, CEO, bought 869,565 with an average share price of $23.00 per share and the total transaction amounting to $19,999,995.00.
Recent Trading for Medpace Holdings, Inc. (NASDAQ:MEDP) Shares of Medpace Holdings, Inc. closed the previous trading session at 27.43 down -0.06 -0.22% with 187,319 shares trading hands.